Accordingly, knock down of two lipid synthesis genes in our ERBB2 network (ACACA and FASN) has been shown to significantly decrease cell viability of the ERBB2-positive breast cancer cell line BT474 (48). The gene discussed is FASN; the disease is breast cancer.